Immunotherapy and Checkpoint Inhibitors: Transforming Cancer Treatment Paradigms. Current Pharmaceutical Letters And Reviews, [S. l.], v. 2, n. 3, p. 1–7, 2026. DOI: 10.62896/. Disponível em: https://cplr.in/index.php/files/article/view/134. Acesso em: 15 apr. 2026.